Molecular pathological analysis of citrullinated proteins in the brain from neurodegenerative disorder patients.
神经退行性疾病患者大脑中瓜氨酸蛋白的分子病理学分析。
基本信息
- 批准号:14570210
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Citrullinated proteins are the products of a post-translational process in which arginine residues undergo modification into citrulline residues when catalyzed by peptidylarginine deiminases(PADs) in a calcium ion-dependent manner. Enzymatic citrullination abolishes positive charges of native protein molecules, inevitably causing significant alterations in their structure and functions. In mammalian tissues, PADs are found as five different isoforms (i.e, types 1-4,6). PAD2 expressed mainly in the rat cerebrum became activated early in the neurodegenerative process. To elucidate the involvement of the citrullination in neuronal degeneration, we examined whether citrullinated proteins are produced in Alzheimer's disease(AD), Parkinson's disease, and Huntington chorea.1.Histochemical analysis revealed that citrullinated proteins were detected all over the hippocampus. However, no citrullinated proteins were detected in the normal hippocampus. PAD2 immunoreactivity was also detected all over the hippocampus both in the AD and the normal brain. Double immunofluorescence staining revealed that citrullinated protein- and PAD2-positive cells were well-coinddenced with GFAP-positive cells, but not all GFAP-positive cells were PAD2-positive cells. As GFAP is a astrocyte-spedfic marker protein, PAD2 is distributed mainly in astrocytes.2.Citrullinated proteins with various molecular weight were detected in AD hippocampus by Western blot analysis, but not in normal brain. Two of the citrullinated proteins were identified as a vimentin and a glial fibrillary acidic protein(GFAP).Thus, abnormal accumulation of citrullinated proteins and abnormal activation of PAD2 is occurring in AD hippocampus. These results strongly suggested that PAD has an important role in the onset and progression of AD and citrullinated proteins may became a possible useful marker for human neurodegenerative disease.
瓜氨酸化蛋白是翻译后过程的产物,当肽精氨酸脱亚胺酶(pad)以钙离子依赖的方式催化时,精氨酸残基被修饰成瓜氨酸残基。酶法瓜氨酸化消除了天然蛋白质分子的正电荷,不可避免地导致其结构和功能的重大改变。在哺乳动物组织中,pad有五种不同的亚型(即1-4,6型)。主要在大鼠大脑中表达的PAD2在神经退行性过程中较早被激活。为了阐明瓜氨酸化在神经元变性中的作用,我们研究了瓜氨酸化蛋白是否在阿尔茨海默病(AD)、帕金森病和亨廷顿舞蹈病中产生。组织化学分析显示,瓜氨酸化蛋白遍布海马。然而,在正常海马中未检测到瓜氨酸化蛋白。在阿尔茨海默病和正常大脑的海马区也检测到PAD2免疫反应性。双免疫荧光染色显示瓜氨酸化蛋白和pad2阳性细胞与gfap阳性细胞一致,但并非所有gfap阳性细胞都是pad2阳性细胞。由于GFAP是星形细胞特异性标记蛋白,PAD2主要分布在星形细胞中。Western blot分析在AD海马中检测到不同分子量的瓜氨酸化蛋白,而在正常脑中未检测到。两个瓜氨酸化蛋白被鉴定为波形蛋白和胶质纤维酸性蛋白(GFAP)。因此,AD海马中出现瓜氨酸蛋白的异常积累和PAD2的异常激活。这些结果强烈提示PAD在AD的发生和发展中起重要作用,瓜氨酸化蛋白可能成为人类神经退行性疾病的有用标记物。
项目成果
期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protein deimination and peptidylarginine deiminase expression during cornification of rat epidermal keratinocytes.
大鼠表皮角质形成细胞角质化过程中的蛋白质脱亚胺化和肽基精氨酸脱亚胺酶表达。
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Ishigami;A.;Asaga;H.;et al.
- 通讯作者:et al.
Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process
- DOI:10.1016/j.exger.2004.04.005
- 发表时间:2004-08-01
- 期刊:
- 影响因子:3.9
- 作者:Jung, KJ;Ishigami, A;Chung, HY
- 通讯作者:Chung, HY
SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span
- DOI:10.1016/j.bbrc.2004.01.091
- 发表时间:2004-03-12
- 期刊:
- 影响因子:3.1
- 作者:Ishigami, A;Kondo, Y;Maruyama, N
- 通讯作者:Maruyama, N
Senescence marker protein-30 (SMP30) regulates Akt activity and contributes to cell survival in Hep G2 cells.
衰老标记蛋白 30 (SMP30) 调节 Akt 活性并有助于 Hep G2 细胞的细胞存活。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Matsuyama;S.;Kitamura;T.;Enomoto;N.;Fujita;T.et al.
- 通讯作者:T.et al.
Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin
- DOI:10.1016/s0003-9861(02)00516-7
- 发表时间:2002-11-01
- 期刊:
- 影响因子:3.9
- 作者:Ishigami, A;Ohsawa, T;Maruyama, N
- 通讯作者:Maruyama, N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIGAMI Akihito其他文献
High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice
预先给予高剂量维生素 C 可降低小鼠万古霉素相关的肾毒性
- DOI:
10.3177/jnsv.65.399 - 发表时间:
2019 - 期刊:
- 影响因子:1.6
- 作者:
TAKIGAWA Masaki;YATSU Tomofumi;TAKINO Yuka;MATSUMOTO Shigekiyo;KITANO Takaaki;LEE Jaewon;ARAI Tomio;TANAKA Hiroyuki;ISHII Toshihiro;MORI Yoshiko;ISHIGAMI Akihito - 通讯作者:
ISHIGAMI Akihito
Acerola (<i>Malpighia emarginata</i> DC.) Promotes Ascorbic Acid Uptake into Human Intestinal Caco-2 Cells via Enhancing the Gene Expression of Sodium-Dependent Vitamin C Transporter 1
针叶樱桃 (<i>Malpighia emarginata</i> DC.) 通过增强钠依赖性维生素 C 转运蛋白 1 的基因表达促进人肠 Caco-2 细胞吸收抗坏血酸
- DOI:
10.3177/jnsv.66.296 - 发表时间:
2020 - 期刊:
- 影响因子:1.6
- 作者:
TAKINO Yuka;AOKI Hitoshi;KONDO Yoshitaka;ISHIGAMI Akihito - 通讯作者:
ISHIGAMI Akihito
Effects of aging and sex differences on IGF-2 and myostatin gene expressions in rat skeletal muscle following resistance training.
抗阻训练后衰老和性别差异对大鼠骨骼肌 IGF-2 和肌生长抑制素基因表达的影响。
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
HUNG Yung-Li;SATO Ayami;TAKINO Yuka;ISHIGAMI Akihito;MACHIDA Shuichi - 通讯作者:
MACHIDA Shuichi
ISHIGAMI Akihito的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIGAMI Akihito', 18)}}的其他基金
Development of diagnostic agent for dementia
痴呆症诊断剂的开发
- 批准号:
24659169 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Effect of vitamin C deficiency on the fetal growth and aging
维生素C缺乏对胎儿生长和衰老的影响
- 批准号:
24380073 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathogenesis and drug development using a mouse model of chronic obstructive pulmonary disease
使用慢性阻塞性肺疾病小鼠模型的发病机制和药物开发
- 批准号:
21590974 - 财政年份:2009
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The elucidation of onset mechanism of Alzheimer's disease.
阐明阿尔茨海默病的发病机制。
- 批准号:
18590355 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Continuing Grant
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
- 批准号:
23K06058 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
- 批准号:
495662 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
- 批准号:
478226 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
Investigation of treatment and prevention methods for Alzheimer's disease targeting orexin neurons
针对食欲素神经元的阿尔茨海默病治疗和预防方法的研究
- 批准号:
23K14364 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of testosterone signaling in microglia: a potential role for sex differences in Alzheimer's Disease
睾酮信号在小胶质细胞中的作用:性别差异在阿尔茨海默病中的潜在作用
- 批准号:
23KJ1699 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting Circadian Clock Dysfunction in Alzheimer's Disease (TClock4AD)
针对阿尔茨海默氏病的生物钟功能障碍 (TClock4AD)
- 批准号:
EP/X030091/1 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant